Report Detail
Global Biotherapeutics Cell Line Market Insights, Forecast to 2025
- RnM3498295 |
- 06 June, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Other
The biocellular therapy industry includes upstream cell storage, midstream cell technology development, and downstream cell therapy.
The downstream of the biological cell therapy industry chain - cell therapy, the implementation of the main body is the top three hospitals; there are two types of downstream industry models: one for the top three hospitals to carry out this business, the other for the top three hospitals and enterprises cooperation, the company provides Technical services and technical support, the hospital provides a clinical platform to implement treatment behavior.
The global Biotherapeutics Cell Line market is valued at 56 million US$ in 2018 and will reach 100 million US$ by the end of 2025, growing at a CAGR of 7.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biotherapeutics Cell Line market based on company, product type, end user and key regions.
This report studies the global market size of Biotherapeutics Cell Line in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biotherapeutics Cell Line in these regions.
This research report categorizes the global Biotherapeutics Cell Line market by top players/brands, region, type and end user. This report also studies the global Biotherapeutics Cell Line market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Becton Dickinson
Beckman Coulter
Boehringer Ingelheim Pharma
CMC Biologics
Catalent
Lonza Group
ProBioGen
Partec
SAFC
Sony Biotechnology
Selexis
Thermo Fisher Scientific
Market size by Product
Single Cell Cloning
Transfection and Selection
Market size by End User
Cancer
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Biotherapeutics Cell Line market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Biotherapeutics Cell Line market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biotherapeutics Cell Line companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Biotherapeutics Cell Line submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Biotherapeutics Cell Line are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biotherapeutics Cell Line market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Biotherapeutics Cell Line Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Biotherapeutics Cell Line Market Size Growth Rate by Product
- 1.4.2 Single Cell Cloning
- 1.4.3 Transfection and Selection
- 1.5 Market by End User
- 1.5.1 Global Biotherapeutics Cell Line Market Size Growth Rate by End User
- 1.5.2 Cancer
- 1.5.3 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Biotherapeutics Cell Line Market Size
- 2.1.1 Global Biotherapeutics Cell Line Revenue 2014-2025
- 2.1.2 Global Biotherapeutics Cell Line Sales 2014-2025
- 2.2 Biotherapeutics Cell Line Growth Rate by Regions
- 2.2.1 Global Biotherapeutics Cell Line Sales by Regions
- 2.2.2 Global Biotherapeutics Cell Line Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Biotherapeutics Cell Line Sales by Manufacturers
- 3.1.1 Biotherapeutics Cell Line Sales by Manufacturers
- 3.1.2 Biotherapeutics Cell Line Sales Market Share by Manufacturers
- 3.1.3 Global Biotherapeutics Cell Line Market Concentration Ratio (CR5 and HHI)
- 3.2 Biotherapeutics Cell Line Revenue by Manufacturers
- 3.2.1 Biotherapeutics Cell Line Revenue by Manufacturers (2014-2019)
- 3.2.2 Biotherapeutics Cell Line Revenue Share by Manufacturers (2014-2019)
- 3.3 Biotherapeutics Cell Line Price by Manufacturers
- 3.4 Biotherapeutics Cell Line Manufacturing Base Distribution, Product Types
- 3.4.1 Biotherapeutics Cell Line Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biotherapeutics Cell Line Product Type
- 3.4.3 Date of International Manufacturers Enter into Biotherapeutics Cell Line Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Biotherapeutics Cell Line Sales by Product
- 4.2 Global Biotherapeutics Cell Line Revenue by Product
- 4.3 Biotherapeutics Cell Line Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Biotherapeutics Cell Line Breakdown Data by End User
6 North America
- 6.1 North America Biotherapeutics Cell Line by Countries
- 6.1.1 North America Biotherapeutics Cell Line Sales by Countries
- 6.1.2 North America Biotherapeutics Cell Line Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Biotherapeutics Cell Line by Product
- 6.3 North America Biotherapeutics Cell Line by End User
7 Europe
- 7.1 Europe Biotherapeutics Cell Line by Countries
- 7.1.1 Europe Biotherapeutics Cell Line Sales by Countries
- 7.1.2 Europe Biotherapeutics Cell Line Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Biotherapeutics Cell Line by Product
- 7.3 Europe Biotherapeutics Cell Line by End User
8 Asia Pacific
- 8.1 Asia Pacific Biotherapeutics Cell Line by Countries
- 8.1.1 Asia Pacific Biotherapeutics Cell Line Sales by Countries
- 8.1.2 Asia Pacific Biotherapeutics Cell Line Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Biotherapeutics Cell Line by Product
- 8.3 Asia Pacific Biotherapeutics Cell Line by End User
9 Central & South America
- 9.1 Central & South America Biotherapeutics Cell Line by Countries
- 9.1.1 Central & South America Biotherapeutics Cell Line Sales by Countries
- 9.1.2 Central & South America Biotherapeutics Cell Line Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Biotherapeutics Cell Line by Product
- 9.3 Central & South America Biotherapeutics Cell Line by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Biotherapeutics Cell Line by Countries
- 10.1.1 Middle East and Africa Biotherapeutics Cell Line Sales by Countries
- 10.1.2 Middle East and Africa Biotherapeutics Cell Line Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Biotherapeutics Cell Line by Product
- 10.3 Middle East and Africa Biotherapeutics Cell Line by End User
11 Company Profiles
- 11.1 Becton Dickinson
- 11.1.1 Becton Dickinson Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Becton Dickinson Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Becton Dickinson Biotherapeutics Cell Line Products Offered
- 11.1.5 Becton Dickinson Recent Development
- 11.2 Beckman Coulter
- 11.2.1 Beckman Coulter Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Beckman Coulter Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Beckman Coulter Biotherapeutics Cell Line Products Offered
- 11.2.5 Beckman Coulter Recent Development
- 11.3 Boehringer Ingelheim Pharma
- 11.3.1 Boehringer Ingelheim Pharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Boehringer Ingelheim Pharma Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Boehringer Ingelheim Pharma Biotherapeutics Cell Line Products Offered
- 11.3.5 Boehringer Ingelheim Pharma Recent Development
- 11.4 CMC Biologics
- 11.4.1 CMC Biologics Company Details
- 11.4.2 Company Business Overview
- 11.4.3 CMC Biologics Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 CMC Biologics Biotherapeutics Cell Line Products Offered
- 11.4.5 CMC Biologics Recent Development
- 11.5 Catalent
- 11.5.1 Catalent Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Catalent Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Catalent Biotherapeutics Cell Line Products Offered
- 11.5.5 Catalent Recent Development
- 11.6 Lonza Group
- 11.6.1 Lonza Group Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Lonza Group Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Lonza Group Biotherapeutics Cell Line Products Offered
- 11.6.5 Lonza Group Recent Development
- 11.7 ProBioGen
- 11.7.1 ProBioGen Company Details
- 11.7.2 Company Business Overview
- 11.7.3 ProBioGen Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 ProBioGen Biotherapeutics Cell Line Products Offered
- 11.7.5 ProBioGen Recent Development
- 11.8 Partec
- 11.8.1 Partec Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Partec Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Partec Biotherapeutics Cell Line Products Offered
- 11.8.5 Partec Recent Development
- 11.9 SAFC
- 11.9.1 SAFC Company Details
- 11.9.2 Company Business Overview
- 11.9.3 SAFC Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 SAFC Biotherapeutics Cell Line Products Offered
- 11.9.5 SAFC Recent Development
- 11.10 Sony Biotechnology
- 11.10.1 Sony Biotechnology Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Sony Biotechnology Biotherapeutics Cell Line Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Sony Biotechnology Biotherapeutics Cell Line Products Offered
- 11.10.5 Sony Biotechnology Recent Development
- 11.11 Selexis
- 11.12 Thermo Fisher Scientific
12 Future Forecast
- 12.1 Biotherapeutics Cell Line Market Forecast by Regions
- 12.1.1 Global Biotherapeutics Cell Line Sales Forecast by Regions 2019-2025
- 12.1.2 Global Biotherapeutics Cell Line Revenue Forecast by Regions 2019-2025
- 12.2 Biotherapeutics Cell Line Market Forecast by Product
- 12.2.1 Global Biotherapeutics Cell Line Sales Forecast by Product 2019-2025
- 12.2.2 Global Biotherapeutics Cell Line Revenue Forecast by Product 2019-2025
- 12.3 Biotherapeutics Cell Line Market Forecast by End User
- 12.4 North America Biotherapeutics Cell Line Forecast
- 12.5 Europe Biotherapeutics Cell Line Forecast
- 12.6 Asia Pacific Biotherapeutics Cell Line Forecast
- 12.7 Central & South America Biotherapeutics Cell Line Forecast
- 12.8 Middle East and Africa Biotherapeutics Cell Line Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biotherapeutics Cell Line Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Biotherapeutics Cell Line . Industry analysis & Market Report on Biotherapeutics Cell Line is a syndicated market report, published as Global Biotherapeutics Cell Line Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Biotherapeutics Cell Line market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
